How the immune system recovers after stem cell transplant
Part of Blood & lymphatic clinical trials.
This study looks at how your immune system (specifically B cells) rebuilds after a stem cell transplant. It may help doctors understand recovery and improve future treatments for blood cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You either have a blood cancer (like myeloma or lymphoma) and are getting a transplant using your own stem cells, OR you have a condition that might need a transplant from a donor, OR you are donating stem cells to someone in this study.
- You must agree to take part in all study activities and sign a consent form.
- You must not have taken part in this trial before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This study looks at immune cells in your blood and in tissues affected by chronic graft-versus-host disease (a condition where donor cells attack your body) after a stem cell transplant. By analyzing samples, researchers hope to better understand this condition and improve future treatments.
This study measures certain immune cells in your blood after a stem cell transplant for acute myeloid leukemia (AML). It aims to understand how well your immune system recovers and may help predict how you'll do after transplant.
This study looks at natural killer (NK) cells, which are part of the immune system, in the blood of people who have had a stem cell transplant for acute leukemia or myelodysplasia. It aims to understand how these cells change after transplant and potentially predict outcomes.
Hear when a new Stem Cell Transplantation, Hematopoietic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.